CDC162P: A Potential Drug Target for Tissue Regeneration and Cellular Processes

Target Name: CCDC162P

NCBI ID: G221262

CCDC162P

CDC162P: A Potential Drug Target for Tissue Regeneration and Cellular Processes

CCDC162P, also known as C6orf184, is a protein that is expressed in various tissues throughout the body. It is a member of the long non-coding RNA (lncRNA) class, which includes RNA molecules that have a length greater than 200 nucleotides but do not have a typical gene structure.

CDC162P has been identified as a potential drug target and has been shown to play a role in a variety of biological processes. Its function is not well understood, but it is known to be involved in the regulation of cellular processes such as cell adhesion, migration, and survival.

One of the key functions of CDC162P is its role in cell adhesion. This protein is involved in the formation of tight junctions, which are a type of cell-cell adhesion that helps to maintain tissue structure and prevent the loss of water.

CDC162P is also involved in the regulation of cell migration. This protein has been shown to be involved in the migration of various cell types, including neural cells, muscle cells, and cancer cells.

In addition to its role in cell adhesion and migration, CDC162P is also involved in the regulation of cell survival. This protein has been shown to play a role in the regulation of apoptosis, which is the process by which cells undergo programmed cell death.

The potential drug target status of CDC162P is supported by several studies. For example, studies have shown that inhibiting the activity of this protein has been shown to result in the inhibition of various cellular processes, including cell adhesion, migration, and survival.

In addition, CDC162P has been shown to be involved in the regulation of cellular signaling pathways. For example, studies have shown that this protein is involved in the regulation of theNotch signaling pathway, which is a pathway that is involved in the regulation of cell growth, differentiation, and survival.

The potential drug targeting of CDC162P is an exciting area of research, with potential implications for the treatment of a variety of diseases. Further studies are needed to fully understand the function of this protein and its potential as a drug target.

Protein Name: Coiled-coil Domain Containing 162, Pseudogene

The "CCDC162P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC162P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets